This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders APAC
New Data, Case Studies & Partners
October 15-16, 2025Marina Bay Sands, Singapore
Book Now
Menu
Book
Key Sessions
Lisa Ooi
Driving Innovation for the Next-Generation RNA Therapeutics in the Asia-Pacific Region
A*STAR
Muthiah (Mano) Manoharan, PhD
Oligonucleotide in the Spotlight - Durable Innovation and delivery of RNAi Therapeutics
Alnylam Pharmaceuticals
keyboard_arrow_right

Day 1 - UTC+08:00

keyboard_arrow_leftSearch & Filter
search
Day 1 - UTC+08:00
search
7:45am - 8:50am
Registration
Showing 1 of 1 Streams
8:50am - 9:00am
RNA Leaders Welcome
  • Jade Osei-Tutu - Head of RNA Leaders, Informa Connect
9:00am - 9:20am
Keynote: mRNA in the Spotlight- a Personalised Medicine, Drug Target, Biomarker, and Vaccines
  • Lisa Ooi - Assistant CEO, A*STAR
9:20am - 10:05am
Driving Innovation for the Next-Generation RNA Therapeutics in the Asia-Pacific Region
  • Lisa Ooi - Assistant CEO, A*STAR
  • Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals
  • Phoebe Dunn - CEO, mRNA Victoria
10:05am - 10:30am
Oligonucleotide in the Spotlight - Durable Innovation and delivery of RNAi Therapeutics
  • Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals
10:30am - 11:15am
Networking Break
Showing 1 of 1 Streams
11:15am - 11:45am
AI-enabled RNA-based diagnosis and therapeutics
  • Sheng Zong - Director, Center for AI in Biomedicine, University of California San Diego
11:45am - 12:15pm
Innovating novel screening systems for the discovery and optimization of ASO and siRNA therapeutics
  • Dillon Flood - Scientific Director, GSK
12:15pm - 12:45pm
circVec – a novel circular RNA expression system to enhance gene and cell therapies
12:45pm - 2:00pm
Lunch
Showing 1 of 1 Streams
2:00pm - 2:30pm
RNAa - The Dawn of a New Therapeutic Era
  • Long-Cheng Li - CEO, Ractigen Therapeutics
2:30pm - 3:00pm
Using siRNA to target Cardiovascular diseases, working from Discovery to Clinical evaluation
  • Zicai Liang - Chairman and CEO, Suzhou Ribo Life Science Co. Ltd.
3:00pm - 3:30pm
Developing Robust mRNA Pharmacology Data for Clinical Advancement
3:30pm - 4:00pm
Networking Break
Showing 1 of 1 Streams
4:00pm - 4:30pm
Deep-Dive into novel LNP modifications and Formulation for next-generation mRNA therapeutics
  • Shiro Akinaga - CEO, NANO MRNA
4:30pm - 5:00pm
Bispecific antibody-mediated cell-selective mRNA-LNP delivery
  • Seth Cheetham - Deputy Director, BASE mRNA facility, The University of Queensland
5:00pm - 5:30pm
Unlocking the Full Potential of RNAi with LEAD Technology
  • Weimin Wang, PhD - Founder & CEO, Sanegene Bio
5:30pm - 6:45pm
Poster & Drinks Reception
NextDay 2
Filter
Streams
Formats
Choose Day